Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient.
Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient, Placebo Controlled Study
Menoufia University
110 participants
Dec 1, 2024
INTERVENTIONAL
Conditions
Summary
The aim of the study is to evaluate the Fertitonex effects on semen parameters in clinical varicocele patients.
Eligibility
Inclusion Criteria3
- Primary infertility.
- Abnormal semen analysis parameters.
- Clinically evident varicocele confirmed by scrotal duplex.
Exclusion Criteria4
- ry infertility.
- Normal semen analysis parameters.
- Clinically non-evident varicocele.
- Past history of varicocelectomy.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Fertitonex which contains L- carnitine L-tartarate 300 mg, L-arginine 241mg, vitamin B6 1.1 mg, vitamin B12 1.7 mcg, vitamin D3 2 mcg, vitamin E 6.5 mg, vitamin C 60 mg, selenium 28 mcg, zinc 7.5 mg, folic acid 300 mcg and CoQ 10 enzyme 7.5 mg in each capsule. The dose will be one capsule twice daily for 3 months.
placebo oral capsule. the dose is twice daily for 3 months
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06718426